Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LARC Study: Three-dimensional Versus Conventional 2D-laparoscopy for Rectocele and Rectal Prolapse Repair: a Prospective, Randomized, Single Center Study.

NCT04817150 is registered in ClinicalTrials.gov with Alexander Khitaryan as lead sponsor.

NCT NCT04817150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LARC Study: Three-dimensional Versus Conventional 2D-laparoscopy for Rectocele and Rectal Prolapse Repair: a Prospective, Randomized, Single Center Study.
Lead sponsor
Alexander Khitaryan
Phase
Not applicable
Overall status
Unknown status
Start date
March 10, 2021
Completion date
July 31, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal prolapse, rectocele and complete uterovaginal prolapse, rectocele and incomplete uterine prolapse, rectocele; female